Moreover, our data here also highlights the importance of organ-site specific research, a recent report using breast cancer models indicated an alternative non-canonical mechanism36, our data in bladder carcinomas implicated the canonical CD167a/DDR1 pathway for activating Stat3. The gene discussed is DDR1; the disease is breast carcinoma.